Scientific research

Global study reveals gaps in microbiota research

A new database of thousands of gut microbiota samples from across the word highlights the need for more diverse microbiota research across the globe.

Newly discovered microbiota-derived bile acids may help treat metabolic conditions

By suggesting that BA–MCYs can regulate the production of bile acids, the findings of a recent study offer insights for treating metabolic conditions such as diabetes.

Synergy between chemical biology and microbiome science may help tackle global issues

Chemical biology offers useful methods to study microbial systems and gather molecular information about microbiomes.

Improving microbiome data reproducibility: key takeaways from Celine Druart (PRI) at the Microbiome Movement event

Celine Druart, from the Pharmabiotic Research Institute, highlighted critical challenges in the microbiome field, particularly around the standardization of clinical protocols and analytical methods. 

Largest study yet links coffee’s health benefits to gut microbes

The effects of coffee on health may be mediated by gut microbes such as L. asaccharolyticus and their metabolites.

Ketogenic diet may help treat autoimmune diseases by altering gut bacteria

The findings suggest that bHB could be a therapeutic alternative to a ketogenic diet. The results also highlight the protective role of the gut microbiota and its metabolites in autoimmune…

Metabolomics in alcohol dependence: uncovering biomarkers and gut-brain interactions through new technologies

Nathalie Maria Delzenne from Université Catholique de Louvain (Belgium) explains how gut microbiota and systemic inflammation impact cravings and depressive symptoms in affected individuals. 

New AI model predicts gut microbial load, revealing its role in health and disease

Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.

Study links gut bacteria to Alzheimer’s, uncovering potential new targets

The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.

New virus-like agents identified in human gut and oral microbiotas

Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top